LAVAL, Qc, April 7 /CNW Telbec/ - BELLUS Health Inc. (TSX: BLU) ("BELLUS
Health" or the "Company") announced today that it issued approximately
34.2 million common shares of the Company to A.R.E. Quebec No. 2, Inc.
("A.R.E."), the landlord of its Laval, Quebec, premises, at a price of
approximately $0.125 per share. The shares were issued as final payment
for the deferred rent in the amount of approximately $4.3 million
payable by BELLUS Health to A.R.E. following the exercise by the
Company of its right to terminate the lease of its Laval premises as of
April 7, 2011, as provided in the amended lease agreement dated March
31, 2009 between the Company and A.R.E.
The Company has signed a new lease that will begin on April 8, 2011 at
the same premises, for less space.
About BELLUS Health
BELLUS Health is a development-focused health company concentrating on
research and development of products that provide innovative health
solutions and address critical unmet medical needs. For further
information, please visit www.bellushealth.com.
Forward Looking Statements
Certain statements contained in this news release, other than statements
of fact that are independently verifiable at the date hereof, may
constitute forward-looking statements. Such statements, based as they
are on the current expectations of management, inherently involve
numerous risks and uncertainties, known and unknown, many of which are
beyond BELLUS Health Inc.'s control. Such risks include but are not
limited to: the impact of general economic conditions, general
conditions in the pharmaceutical and/or nutraceutical industry, changes
in the regulatory environment in the jurisdictions in which the BELLUS
Health Group does business, stock market volatility, fluctuations in
costs, and changes to the competitive environment due to consolidation,
that actual results may vary once the final and quality-controlled
verification of data and analyses has been completed, as well as other
risks disclosed in public filings of BELLUS Health Inc. Consequently,
actual future results may differ materially from the anticipated
results expressed in the forward-looking statements. The reader should
not place undue reliance, if any, on any forward-looking statements
included in this news release. These statements speak only as of the
date made and BELLUS Health Inc. is under no obligation and disavows
any intention to update or revise such statements as a result of any
event, circumstances or otherwise, unless required by applicable
legislation or regulation. Please see the Annual Information Form of
BELLUS Health Inc. for further risk factors that might affect the
BELLUS Health Group and its business.
SOURCE BELLUS HEALTH INC.
For further information: